Chronic respiratory failure due to chronic obstructive pulmonary disease (COPD) is an
increasing problem worldwide. Many patients with severe COPD develop hypoxemic …

Long term oxygen therapy (LTOT) has been shown to improve the survival rate in Chronic
Obstructive Pulmonary Disease (COPD) patients with severe resting hypoxemia by NOTT …

Long-term oxygen therapy (LTOT) is the treatment proven to improve survival in chronic
obstructive pulmonary disease (COPD) patients with chronic respiratory failure. It also …

Long-term oxygen therapy (LTOT) is a mainstay treatment for patients with severe resting
hypoxemia secondary to chronic respiratory conditions including COPD. The evidence for …

Long-term oxygen therapy (LTOT) improves prognosis in patients with COPD and chronic
severe hypoxemia. The efficacy in moderate hypoxemia (tension of arterial oxygen; on air …

Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and death
globally, characterised by progressive breathlessness, loss of function and, in its later …

Long-term oxygen treatment (LTOT) prolongs life in patients with chronic obstructive
pulmonary disease (COPD) and severe resting hypoxemia. Although this benefit is proven …

This study aimed to review the evidence for the use of long-term oxygen therapy for patients
with chronic obstructive pulmonary disease (COPD). The design was a systematic Cochrane …

PREVIEW The role of long-term oxygen therapy for hypoxemia in patients with chronic
obstructive pulmonary disease is well established. Determining appropriate candidates and …

Background Long-term oxygen therapy (LTOT) is an established treatment for patients with
chronic hypoxemia. Its scientific basis is derived mainly from two trials from the early 1980s …